Original filing text · Part I

Item 3 — Quantitative and Qualitative Disclosures About Market Risk

Fulgent Genetics, Inc. · 10-Q · Q2 FY2026 · Period ended Jun 30, 2026

This is the extracted source text from the SEC filing. Formatting may differ from the original document.

For quantitative and qualitative disclosures about market risk, see Part II, “Item 7A. Quantitative and Qualitative Disclosures About Market Risk,” in the 2025 Annual Report. There were no material changes during the six months ended June 30, 2026.